BTAI BioXcel Therapeutics, Inc.
Healthcare$1.22+7.96%ClosedMarket Cap: $37.7M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$12.00
Target (Median)
$10.00
Target Range
$1.00 - $25.00
Upside from current price: 883.6%
Rating Distribution
0 Strong Buy3 Buy0 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-02 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-15 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-12 | Mizuho | maintain | Neutral | Neutral |
| 2025-08-15 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-07-15 | LUCID CAPITAL MARKETS | maintain | Buy | Buy |
| 2025-06-23 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-2.63 | $1.5M | 2 |
| Fri Dec 31 | $-1.53 | $18.9M | 2 |
| Sun Dec 31 | $-0.79 | $63.3M | 1 |
| Mon Dec 31 | $-0.62 | $178.8M | 1 |